Production (Stage)
Connect Biopharma Holdings Limited
CNTB
$0.9799
$0.02993.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.74% | 0.00% | -404.31% | 144.00% | 45.04% |
| Total Depreciation and Amortization | 88.04% | 0.00% | -61.34% | 45.12% | 53.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -71.23% | 0.00% | 182.03% | -26.98% | -19.96% |
| Change in Net Operating Assets | -148.90% | 0.00% | 113.42% | -233.30% | 14.06% |
| Cash from Operations | -27.37% | 0.00% | -96.11% | -574.62% | 92.87% |
| Capital Expenditure | 48.41% | 0.00% | 27.98% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -166.80% | 0.00% | -221.25% | -31.28% | -54.53% |
| Cash from Investing | -162.47% | 0.00% | -228.11% | -33.64% | -54.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00% | 200.00% | -- | -- |
| Issuance of Common Stock | -96.80% | 0.00% | 22.55% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.53% | 0.00% | 693.48% | -- | -- |
| Foreign Exchange rate Adjustments | 129.70% | 0.00% | -461.11% | 79.64% | -24.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -93.20% | 0.00% | -858.29% | -75.31% | -30.02% |